Solving the Problem of Insolubility: Part II
February 24, 2026
KinetiSol’s solvent-free mixing process turns “brick dust” drugs into stable amorphous dispersions
5 min read
False
February 24, 2026
KinetiSol’s solvent-free mixing process turns “brick dust” drugs into stable amorphous dispersions
5 min read
February 23, 2026
New technology enables faster design cycles and improved editing precision
1 min read
February 23, 2026
An Interview with Adam Davenport, CSO, Concept Life Sciences
4 min read
February 20, 2026
Integrated, risk-based chemistry, manufacturing and controls strategies support early-phase development, writes Richard Chubb
6 min read
February 19, 2026
Here’s how next-generation cell line and manufacturing methods can boost productivity, improve purity, and remove bottlenecks in bispecific antibody development
12 min read
February 19, 2026
Scaling genomics with AI and automation is one thing, but building the infrastructure to support it is what will really drive innovation in the space
3 min read
February 19, 2026
New board will identify opportunities for the advanced therapies sector to deploy and benefit from innovations
2 min read
February 18, 2026
Greg Thomas, Kiel Laboratories’ Vice President of R&D, discusses oral suspensions, excipients, and patient-centered formulation
4 min read
February 18, 2026
Regulatory filing for Arexvy has been accepted for review in China for adults aged 60 and older, where RSV affects millions each year
2 min read
February 17, 2026
Phase 3 results show fenebrutinib matched OCREVUS on disability progression in PPMS
2 min read
False
False
False